Search Results 1941-1950 of 16078 for Epilepsy (Partial Onset)
Subject has Parkinson's disease consistent with the UK Brain Bank Criteria and must have bradykinesia with sequence effect. · Subject with disease duration less ...
... duration of the study. Patients utilizing cannabinoid based substances may be included if no dose changes are made during the duration of the study; Patients ...
A total of 8,000 patients presenting to CPSs with acute-onset AIS, ICH or aSAH and no history of dementia will be enrolled within 6 weeks of stroke onset.
About this study. This trial will evaluate the safety and effectiveness of pembrolizumab (MK-3475) in combination with platinum doublet neoadjuvant ...
premonitory), develop an initial migraine prediction algorithm, and to provide insights into how long prior to headache onset premonitory changes begin. It ...
Randomized Placebo-Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy. Ann Neurol. 2020 Feb; 87 (2):313-323 Epub 2019 Dec 14
The purpose of this study is to assess the side effects and best dose of a genetically engineered measles virus for treating patients who have a cancerous ...
Vuity® eye drops and Qlosi™ eye drops are used to treat presbyopia (age-related eye or vision problem). This medicine is available only with your doctor's ...
Participation eligibility · Onset of chronic migraine at least 6 months prior to start of Screening determined by a well-documented history · Evidence of ...
onset of menopause, must agree to use an acceptable form of birth control until 28 days following the last dose of the study drug, and females must agree to ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.